Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Nootropics Depot Launches Safralis, the highest and purest grade of Kashmir Saffron

Nootropics Depot is a leading supplement company setting benchmark standards for quality and transparency in the industry. Founded with a mission to empower consumers with knowledge about what they put into their bodies, Nootropics Depot offers a wide range of high-quality cognitive enhancement and general health supplements.

News provided by

Nootropics Depot

Oct 08, 2026, 17:24 ET

Share this article

Share toX

Share this article

Share toX

Built on a direct farm-to-capsule supply chain in the Kashmir valley, Safralis is cold-milled whole stigma rather than an extract.

TEMPE, Ariz., Oct. 8, 2026 /PRNewswire/ -- Nootropics Depot has launched Safralis, a high-potency Kashmir saffron made from whole stigma that is cold-milled rather than extracted, and standardized to 8% crocins and 3% safranals. Nootropics Depot uses exclusively Mongra-grade Kashmiri saffron, one of the region's most prized grades. Its whole-stigma powder delivers exceptionally high concentrations of key bioactive compounds, ranking among the most potent saffron products on the market beating out all of the major commercially available extracts. The company is fully transitioning its saffron products to Safralis.

Safralis: whole Mongra saffron from Kashmir, standardized to 8 percent crocins and 3 percent safranals.
Safralis: whole Mongra saffron from Kashmir, standardized to 8 percent crocins and 3 percent safranals.
Safralis is cold-milled whole saffron stigma; chilled milling with acacia fiber stabilizes the volatile safranal.
Safralis is cold-milled whole saffron stigma; chilled milling with acacia fiber stabilizes the volatile safranal.

Safralis supports a positive mood, promotes cognitive function, and supports oxidative defenses and neuronal protection, functions backed by one of the deepest research bases of any botanical in its category. The mood evidence includes multiple randomized, placebo-controlled human trials plus systematic reviews and meta-analyses indicating that saffron supplementation supports mood and emotional wellbeing in healthy adults. The cognitive evidence spans human randomized trials, meta-analysis, and mechanistic work on crocin, crocetin, and safranal that research suggests supports cognitive function and attention. Crocin consistently supports oxidative defenses, including lipid peroxidation, DNA damage, and antioxidant enzymes, across cell, animal, and human research, including a placebo-controlled human trial. Each benefit is published on the Saffron Research Snapshot with its studies, part of Nootropics Depot's research transparency pages.

The decision not to extract is what separates Safralis from the rest of the market. When you extract saffron you concentrate some compounds but lose others, and you can only extract what the plant makes naturally. Rather than build the most potent extract, Nootropics Depot went looking for the best raw material first. Saffron is prized for its color and aroma, and those qualities indicate the level of its bioactives, so the starting material determines the ceiling.

"You can only extract what the plant makes natively, so the smarter move is to find the best raw plant material first, via strain and region selection, then optimize its growing conditions to make the highest native amount of bioactives possible," said Paul Eftang, CEO of Nootropics Depot. "We have made some of the most potent extracts in the world, and that experience is exactly why we chose the whole stigma here. Whenever you extract, you concentrate some compounds, but you always lose others. We wanted to keep the full spectrum of saffron bioactives intact, and if you can get extract level amounts of bioactives natively, why extract at all?"

To preserve that material, Safralis is cold-milled: the mill is chilled and the threads are ground with acacia fiber, which stabilizes the volatile safranal. Botanical identity is verified by HPTLC, and the product was developed in partnership with the scientists at Omnient Labs, who created more advanced methods for testing the bioactives in saffron. Safranal is measured together with its precursors picrocrocin and HTCC.

Securing whole Mongra stigma at this standard required control of the source. Kashmir produces less than 1% of the world saffron supply, and Mongra is a small fraction of that output. Nootropics Depot built a new direct farm-to-capsule supply chain in the Kashmir valley, working with longtime partners and relationships built over years. The global saffron trade has seen supply disruption and origin opacity, and direct sourcing gives Nootropics Depot full origin control and verification.

"It was no easy task to set up a reliable supply chain in Kashmir. The trust we built with the farmers there took a long time and a lot of work, and it is what made this product possible," Eftang said. "An industry that wants consumer confidence has to control the whole process, from farm to capsule, and not just place its trust blindly in middle men."

The no-extraction approach follows the method Nootropics Depot used for Erinamax, which produced the most potent erinacine A lion's mane available by starting with superior raw material instead of concentrating it afterward. Nootropics Depot's previous saffron extract was already the most potent on the market.

Safralis is offered in two strengths: 15 mg and 30 mg capsules. It can be taken once or twice a day. Both capsules deliver the same 8% crocins and 3% safranals. We decided to offer 15mg capsules, because the 30mg ones are a bit too strong for some people. It also allows for the ability to split the dose into morning and evening.

Safralis is the latest release in Nootropics Depot's run of analytical and sourcing projects, following SulfoMax, the company's highest-sulforaphane supplement at 27 mg of active sulforaphane per serving.

About Nootropics Depot

Nootropics Depot is a leading supplement company setting benchmark standards for quality and transparency in the industry. Founded in 2013, Nootropics Depot's mission has been to educate consumers on the science behind dietary supplements, and to advance the lab testing and quality control standards of the industry. Their stance is that consumers should be able to trust the products they buy, and that the brands selling those products have a duty to ensure they are using modern validated science. Nootropics Depot offers a wide range of high-quality cognitive enhancement and general health supplements. The company's commitment to quality and transparency is evident in their rigorous testing procedures, easily accessible Certificates of Analysis (COAs), and lab testing results available on every product page. In addition, they have formed a Scientific Advisory Board with board certified doctors, PhD researchers, and botanists to ensure that consumers can trust that scientific rigor is being upheld in everything they do. For more information, visit nootropicsdepot.com.

Media Contact:
Michael Packman, Nootropics Depot
[email protected]

SOURCE Nootropics Depot

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Nootropics Depot Sponsors Future Nutra Innovation Summit

Nootropics Depot Sponsors Future Nutra Innovation Summit

Nootropics Depot will serve as a headline sponsor of the Future Nutra Innovation Summit, or FNIS, taking place Sept. 9-11, 2026, at Margaritaville...

Nootropics Depot Launches SulfoMax, the World's Highest Sulforaphane Supplement

Nootropics Depot Launches SulfoMax, the World's Highest Sulforaphane Supplement

Nootropics Depot released SulfoMax, a powdered supplement that delivers 27mg of active sulforaphane per serving, a level the company states is the...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Pharmaceuticals

Pharmaceuticals

Cosmetics and Personal Care

Cosmetics and Personal Care

Supplementary Medicine

Supplementary Medicine

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.